Detalles de la búsqueda
1.
A randomized phase 1b trial of the active site polymerase inhibitor nucleotide ATI-2173 in patients with chronic hepatitis B virus infection.
J Viral Hepat
; 30(1): 19-28, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36201354
2.
Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection.
J Antimicrob Chemother
; 77(4): 1102-1110, 2022 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35040959
3.
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy.
Gastroenterology
; 158(8): 2180-2194, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32147484
4.
Benefit of transaminase elevations in establishing functional cure of HBV infection during nap-based combination therapy.
J Viral Hepat
; 28(5): 817-825, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33556206
5.
HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.
Hepatol Commun
; 6(8): 1870-1880, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35368148
6.
Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitis.
Aliment Pharmacol Ther
; 55(4): 401-411, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35014040
7.
Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy.
Hepatol Commun
; 5(11): 1873-1887, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34558823
8.
Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis? Authors' reply.
Aliment Pharmacol Ther
; 55(6): 735-736, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35245951
Resultados
1 -
8
de 8
1
Próxima >
>>